NCT00768001|Terminated
Study Stopped
low accrual
Loading search results
low accrual
Sponsor study identifier
Secondary identifiers
OTHER · SU
observational
41
1 country
1
Study Start
June 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2011
Actual (reported)Study Completion
October 2011
Actual (reported)Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of liver cancer influences clinical outcome and treatment response. We are developing a translational research program that will characterize molecular changes in liver cancer. We plan to use molecular information obtained from studying liver tumor tissues to develop new diagnostics and treatment regimens for patients with these cancers. The experimental approach will require freezing fresh tumor tissues obtained from surgical procedures, which will be subsequently used for analysis of DNA, protein and mRNA expression. Many patients with liver cancer are referred to the Stanford Liver Tumor Board for consultation and treatment recommendations. We propose to gather tissue samples from those who subsequently undergo biopsy, liver resection surgery, or transplant surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2008
Date type not reportedThis date has not been verified as actual or estimated.
October 3, 2008
Actual (reported)October 7, 2008
Actual (reported)October 2011
Actual (reported)October 2011
Actual (reported)liver cancer patients
Contact the study team to confirm eligibility.
Stanford University School of Medicine
Stanford, California, 94305, United States
tumor sample
Samuel So
Stanford University
41 participants (actual enrollment reported by the registry).
First Submitted
October 3, 2008
First Posted
October 7, 2008
Study Start
June 2008
Date type not reportedThis date has not been verified as actual or estimated.
Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Primary Completion
October 2011
Actual (reported)Study Completion
October 2011
Actual (reported)Last Updated
February 1, 2012
Record last verified: 2012-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: